Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone
Authors
Keywords
-
Journal
Expert Review of Proteomics
Volume 12, Issue 6, Pages 695-701
Publisher
Informa UK Limited
Online
2015-10-24
DOI
10.1586/14789450.2015.1099436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis
- (2014) Tingting Shu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study
- (2014) A. Maccio et al. HAEMATOLOGICA
- Identification of erythroferrone as an erythroid regulator of iron metabolism
- (2014) Léon Kautz et al. NATURE GENETICS
- Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer
- (2013) R. Orlandi et al. ANNALS OF ONCOLOGY
- Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells
- (2013) Bryan J. McCranor et al. BLOOD CELLS MOLECULES AND DISEASES
- Guideline for the laboratory diagnosis of functional iron deficiency
- (2013) D. Wayne Thomas et al. BRITISH JOURNAL OF HAEMATOLOGY
- Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification1)
- (2013) Anna Durigova et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Bone morphogenetic proteins and the polycystic ovary syndrome
- (2013) E Leonie AF van Houten et al. Journal of Ovarian Research
- Hepcidin and iron homeostasis
- (2012) Tomas Ganz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Circulating Human Hepcidin-25 Concentrations Display a Diurnal Rhythm, Increase with Prolonged Fasting, and Are Reduced by Growth Hormone Administration
- (2012) J. S. Troutt et al. CLINICAL CHEMISTRY
- HEPCIDIN, ANAEMIA, AND PROSTATE CANCER
- (2011) Toshihiko Tanno et al. BJU INTERNATIONAL
- Serum hepcidin: reference ranges and biochemical correlates in the general population
- (2011) T. E. Galesloot et al. BLOOD
- In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2
- (2010) K. Maes et al. BLOOD
- Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?
- (2010) Emma-Leena Alarmo et al. ENDOCRINE-RELATED CANCER
- Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma
- (2009) Takao Kamai et al. BMC CANCER
- Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD
- (2009) Guillem Casanovas et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Immunoassay for human serum hepcidin
- (2008) T. Ganz et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search